Tom Brady recently disclosed an intriguing personal development: he successfully cloned his late dog, Lua, with assistance from Colossal Biosciences. This Dallas-based biotechnology firm gained notoriety for its innovative “dire wolf” project that captured the public’s attention.
Earlier this year, Colossal Biosciences made headlines by announcing its ambitious endeavor to revive the extinct dire wolf using gene-editing techniques on contemporary gray wolf cells. Their pioneering efforts extend beyond this project, as the company has also set its sights on the woolly mammoth and Tasmanian tiger, combining cutting-edge science with attention-grabbing narratives that frequently trend on social media.
Brady, who mourned the loss of his pit bull mix, Lua, in December 2023, revealed that Colossal’s specialized division, Viagen Pets & Equine, facilitated the cloning of his new dog, Junie. According to People, this process began with a blood sample taken from Lua prior to her passing, allowing the company to recreate her through a “non-invasive” cloning technique that Brady found emotionally comforting.

Tom Brady’s emotional tribute to Lua on Instagram
A New Beginning: Brady Sees Junie as a ‘Second Chance’
In a heartfelt statement shared through People, Brady expressed, “I love my animals. They mean the world to me and my family. A few years ago, I worked with Colossal and leveraged their non-invasive cloning technology through a simple blood draw of our family’s elderly dog before she passed.”
Junie, the outcome of this innovative process, is genetically identical to Lua. Brady regards this development as a significant “second chance” to reconnect with a cherished member of his family.
Colossal Biosciences is not only building a reputation for resurrecting ancient species, but it is also making waves in the world of pet cloning by facilitating one of football’s most celebrated figures in reclaiming companionship with man’s best friend.
Leave a Reply